NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 27, 2026 $4.48 +4.27% $4.40 V 98.10% 1
Jan 27, 2026 $4.19 -2.67% $4.40 X 95.12% 0
Jan 27, 2026 Bullish $4.40 V 1
Jan 22, 2026 $4.38 -4.31% $4.51 V 97.17% 1
Jan 22, 2026 $4.46 -2.69% $4.51 V 98.82% 2
Jan 22, 2026 Bullish $4.51 V 0
Jan 20, 2026 $4.17 +4.84% $4.32 V 96.59% 1
Jan 20, 2026 $3.86 -3.02% $4.32 X 89.34% 0
Jan 20, 2026 Bullish $4.32 V 1
Jan 12, 2026 $3.64 +5.20% $4.11 V 88.56% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE